ABVC
ABVC BioPharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.96
−3.99%Aug 27, 2026, 00:00 UTC
ABVC BioPharma, Inc. completed the spin-off of its subsidiary BioKey (Cayman), Inc. by distributing approximately 15% of BioKey's ordinary shares to ABVC stockholders as a pro rata dividend, effective August 21, 2026.